Target intelligence / Profile preview

Arabinofuranosyl residues on substituted xylan (AX)

Target
AX
Molecular classification
Carbohydrate, Polysaccharide, Hemicellulose, Dietary fiber
01

Overview

Arabinofuranosyl residues on substituted xylan are key structural components of arabinoxylan, a major hemicellulose found in the cell walls of cereal grains such as wheat, rye, and barley (Scheller & Ulvskov, 2010). These residues consist of alpha-L-arabinofuranose units linked to the C(O)-2 and/or C(O)-3 positions of the beta-1,4-linked D-xylopyranosyl backbone. The pattern and degree of this substitution significantly influence the physicochemical properties of the polymer, including its water solubility, viscosity, and susceptibility to enzymatic degradation (Izydorczyk & Biliaderis, 1995). While not a traditional human therapeutic protein target, these residues serve as critical substrates for various carbohydrate-active enzymes (CAZymes), such as alpha-L-arabinofuranosidases, which are utilized in industrial biotechnology and as digestive aids to improve the nutritional value of animal feed and human diets. In the human gut, these residues are fermented by specific microbiota, such as Bifidobacterium species, leading to the production of beneficial short-chain fatty acids (SCFAs) like butyrate and propionate, which play roles in maintaining intestinal health and metabolic homeostasis (Riviere et al., 2016).

Other names
ArabinoxylanL-Arabinofuranosyl side chainsAlpha-L-arabinofuranosyl residuesXylan arabinosyl groups
02

Mechanism of action

Enzymatic hydrolysis of the alpha-1,2 or alpha-1,3 glycosidic linkages by specific glycoside hydrolases (such as GH43 and GH51 families) to release arabinose and expose the xylan backbone for further degradation by xylanases.

03

Biological functions

Plant cell wall structural integrityPrebiotic substrateRegulation of postprandial glycemic responseIntestinal motility enhancementShort-chain fatty acid production
04

Disease associations

Metabolic syndromeType 2 diabetesObesityConstipationGut dysbiosis
05

Safety considerations

Gastrointestinal bloatingFlatulenceAbdominal discomfortOsmotic diarrhea at high intake levels
06

Interacting drugs

Alpha-L-arabinofuranosidase

2 more in the full profile.

07

Biomarkers

Fecal short-chain fatty acids (SCFAs)Bifidobacterium abundanceGlycemic index reduction

Beyond the preview

Go deeper on Arabinofuranosyl residues on substituted xylan (AX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arabinofuranosyl residues on substituted xylan (AX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call